VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI

November 7, 2022 updated by: Sunnaas Rehabilitation Hospital

Virtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With Acquired Brain Injury

One hundred participants with acquired brain injury (ABI) will be included in a randomized controlled trial, with one group playing a commercially available VR game and the control group doing activities in their everyday as cognitive training. The trial aims to investigate how VR can affect processing speed in the ABI population, and if these effects can transfer into everyday activities. The training will be performed in the participants homes, with assistance provided by the project group via phone or video conference. The training period will last five weeks. Participant's cognitive functions will be measured with questionnaires and neuropsychological tests at the start of the training period, at the end of training and sixteen weeks after the start of the intervention. In depth experiences with VR as a training method will be gathered through performing focus group interviews with some of the participants from the VR group, in addition to self-reported questionnaires from all the participants.

Study Overview

Detailed Description

A randomized controlled trial (RCT) will be conducted where the experimental intervention is playing a commercial VR game. The VR group will follow a training regime of a 30 min VR session five times per week for 5 weeks. The control group will carry on with treatment as usual, in addition, participants will receive an information booklet covering cognitive training in everyday life. Baseline and outcome measures in terms of neuropsychological assessment and questionnaires will be performed at baseline (T1), at the end of the intervention period (T2) and at the 16-week follow-up (T3).

The VR group will train with a rhythm VR game that is considered as a good candidate for basic training of the multifaceted aspects of attention including speed of information processing, selection, sustained attention, shifting/dividing of attention, and working memory.

The VR game is selected on the grounds of clinical experience with VR training of processing speed, attention and working memory, and is also suggested in research as suitable games for cognitive rehabilitation.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients in stable phase after Acquired brain injury, minimum one year after injury
  • Physically able to operate VR-technology
  • Norwegian or English skills adequate to understand instructions, play the VR-games and to provide valid responses to assessment methods

Exclusion Criteria:

  • Severe aphasia affecting their understanding of instructions
  • Apraxia affecting their ability to use VR-equipment
  • Visual neglect
  • Severe mental illness, substance abuse or co-existing neurological disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Group
Group 1 will play a VR game using an Oculus Quest 2 in a home setting
Game to be played is a commercially available VR game
Other Names:
  • Oculus Quest 2
Active Comparator: Active control group
The control group will be given a pamphlet containing exercises affecting working memory, attention and processing speed to be performed in a home setting
Sodoku, crossword puzzles

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in processing speed
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Connors Continous Performance test 3rd edition, Coefficient of Variation
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patient reported executive functioning
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Behavior Rating Inventory of Executive function (BRIEF-A)
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Transfer effect to everyday activities
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Patient Competency Rating Scale
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in working memory
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Wechslers Adult Intelligence Scale IV, Backwards Digit Span
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in working memory
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Wechslers Adult Intelligence Scale IV, Digit sequencing test
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in informant reported executive functioning
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Behavior Rating Inventory of Executive function (BRIEF-A)
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Change in sustained attention
Time Frame: Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)
Connors Continous Performance test 3rd edition, Performance variability over time
Measured at baseline, after the intervention period (5 weeks) and at follow-up (16 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marianne Løvstad, PhD, Sunnaas Rehabilitation hopsital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2022

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

May 19, 2022

First Submitted That Met QC Criteria

June 29, 2022

First Posted (Actual)

July 5, 2022

Study Record Updates

Last Update Posted (Actual)

November 8, 2022

Last Update Submitted That Met QC Criteria

November 7, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Data will be deidentified and will not be made publicly available due to data protection regulations

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Virtual Reality

Subscribe